A detailed history of Moors & Cabot, Inc. transactions in Becton Dickinson & CO stock. As of the latest transaction made, Moors & Cabot, Inc. holds 8,678 shares of BDX stock, worth $1.93 Million. This represents 0.11% of its overall portfolio holdings.

Number of Shares
8,678
Previous 8,084 7.35%
Holding current value
$1.93 Million
Previous $1.89 Million 10.75%
% of portfolio
0.11%
Previous 0.1%

Shares

33 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 08, 2024

BUY
$221.47 - $242.41 $131,553 - $143,991
594 Added 7.35%
8,678 $2.09 Million
Q2 2024

Aug 09, 2024

BUY
$225.07 - $246.17 $129,865 - $142,040
577 Added 7.69%
8,084 $1.89 Million
Q1 2024

May 08, 2024

SELL
$233.45 - $247.73 $234,383 - $248,720
-1,004 Reduced 11.8%
7,507 $1.86 Million
Q4 2023

Feb 14, 2024

BUY
$232.24 - $267.23 $85,464 - $98,340
368 Added 4.52%
8,511 $2.08 Million
Q3 2023

Nov 07, 2023

SELL
$254.9 - $283.59 $30,842 - $34,314
-121 Reduced 1.46%
8,143 $2.11 Million
Q2 2023

Aug 09, 2023

SELL
$238.39 - $265.32 $89,634 - $99,760
-376 Reduced 4.35%
8,264 $2.18 Million
Q1 2023

May 04, 2023

SELL
$229.71 - $259.35 $43,185 - $48,757
-188 Reduced 2.13%
8,640 $2.14 Million
Q4 2022

Feb 09, 2023

BUY
$218.29 - $256.91 $225,275 - $265,131
1,032 Added 13.24%
8,828 $2.25 Million
Q4 2022

Feb 06, 2023

SELL
$218.29 - $256.91 $416,497 - $490,184
-1,908 Reduced 19.66%
7,796 $1.98 Million
Q3 2022

Nov 07, 2022

SELL
$51.03 - $264.23 $16,737 - $86,667
-328 Reduced 3.27%
9,704 $2.16 Million
Q2 2022

Aug 08, 2022

BUY
$234.74 - $275.42 $48,121 - $56,461
205 Added 2.09%
10,032 $2.47 Million
Q1 2022

May 13, 2022

BUY
$243.64 - $270.48 $486,061 - $539,607
1,995 Added 25.47%
9,827 $2.61 Million
Q4 2021

Feb 14, 2022

BUY
$230.08 - $250.94 $71,094 - $77,540
309 Added 4.11%
7,832 $1.97 Million
Q3 2021

Dec 08, 2021

SELL
$232.72 - $256.47 $5.07 Million - $5.59 Million
-21,802 Reduced 74.35%
7,523 $1.85 Million
Q3 2021

Nov 05, 2021

BUY
$232.72 - $256.47 $5.18 Million - $5.71 Million
22,252 Added 314.6%
29,325 $1.05 Million
Q2 2021

Aug 10, 2021

BUY
$232.65 - $254.58 $42,109 - $46,078
181 Added 2.63%
7,073 $1.72 Million
Q1 2021

May 12, 2021

SELL
$232.09 - $256.88 $426,813 - $472,402
-1,839 Reduced 21.06%
6,892 $1.68 Million
Q4 2020

Feb 11, 2021

BUY
$221.92 - $245.94 $28,183 - $31,234
127 Added 1.48%
8,731 $2.19 Million
Q3 2020

Nov 09, 2020

BUY
$215.77 - $276.76 $192,466 - $246,869
892 Added 11.57%
8,604 $2 Million
Q2 2020

Aug 13, 2020

SELL
$219.9 - $263.41 $56,074 - $67,169
-255 Reduced 3.2%
7,712 $1.85 Million
Q1 2020

May 12, 2020

SELL
$195.69 - $279.01 $548,714 - $782,344
-2,804 Reduced 26.03%
7,967 $1.83 Million
Q4 2019

Jan 28, 2020

SELL
$236.45 - $266.82 $120,353 - $135,811
-509 Reduced 4.51%
10,771 $2.93 Million
Q3 2019

Oct 22, 2019

BUY
$230.58 - $256.08 $364,085 - $404,350
1,579 Added 16.28%
11,280 $2.85 Million
Q2 2019

Jul 18, 2019

BUY
$217.4 - $246.08 $6,522 - $7,382
30 Added 0.31%
9,701 $2.45 Million
Q1 2019

May 06, 2019

SELL
$206.05 - $248.17 $1.99 Million - $2.4 Million
-9,671 Reduced 50.0%
9,671 $2.42 Million
Q1 2019

May 01, 2019

BUY
$206.05 - $248.17 $1.86 Million - $2.24 Million
9,020 Added 87.39%
19,342 $4.83 Million
Q4 2018

Feb 13, 2019

BUY
$204.73 - $257.93 $195,312 - $246,065
954 Added 10.18%
10,322 $2.33 Million
Q3 2018

Nov 14, 2018

BUY
$233.07 - $256.0 $221,649 - $243,456
951 Added 11.3%
9,368 $2.45 Million
Q2 2018

Aug 14, 2018

SELL
$208.1 - $233.85 $78,037 - $87,693
-375 Reduced 4.27%
8,417 $2.02 Million
Q1 2018

May 18, 2018

BUY
$205.46 - $240.27 $69,856 - $81,691
340 Added 4.02%
8,792 $1.91 Million
Q4 2017

Feb 13, 2018

BUY
$189.0 - $222.64 $9,450 - $11,132
50 Added 0.6%
8,452 $1.81 Million
Q3 2017

Nov 16, 2017

BUY
$186.89 - $198.9 $257,534 - $274,084
1,378 Added 19.62%
8,402 $1.65 Million
Q2 2017

Aug 15, 2017

BUY
N/A
7,024
7,024 $1.38 Million

Others Institutions Holding BDX

About BECTON DICKINSON & CO


  • Ticker BDX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 285,195,008
  • Market Cap $63.3B
  • Description
  • Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company's BD Medical segment offers peripheral intravenou...
More about BDX
Track This Portfolio

Track Moors & Cabot, Inc. Portfolio

Follow Moors & Cabot, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Moors & Cabot, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Moors & Cabot, Inc. with notifications on news.